Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H20N2 |
Molecular Weight | 216.322 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCC1=CNC2=CC=CC=C12
InChI
InChIKey=LSSUMOWDTKZHHT-UHFFFAOYSA-N
InChI=1S/C14H20N2/c1-3-16(4-2)10-9-12-11-15-14-8-6-5-7-13(12)14/h5-8,11,15H,3-4,9-10H2,1-2H3
Molecular Formula | C14H20N2 |
Molecular Weight | 216.322 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096904 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5306645 |
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods. | 2008 Feb 15 |
|
A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. | 2008 Jan 15 |
|
Optimization of separation and online sample concentration of N,N-dimethyltryptamine and related compounds using MEKC. | 2009 Feb |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:04 GMT 2023
by
admin
on
Fri Dec 15 14:58:04 GMT 2023
|
Record UNII |
916E8V4S2V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs- Diethyltryptamine
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
||
|
DEA NO. |
7434
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
||
|
WIKIPEDIA |
TiHKAL
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID9052763
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
6090
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
C038927
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
DB01460
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
PD 001
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
916E8V4S2V
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
61-51-8
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY | |||
|
Diethyltryptamine
Created by
admin on Fri Dec 15 14:58:04 GMT 2023 , Edited by admin on Fri Dec 15 14:58:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->WEAK AGONIST |
Hallucinogenic, 31% of the stimulation of 5-hydroxytryptamine. Stimulation of phosphoinositide hydrolysis.
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|